A member of India’s parliament asked Prime Minister Narendra Modi yesterday to cap the prices on 20 medical devices, in addition to the orthopedic and cardiac products that are already cost-limited there. The caps enacted by India’s National Pharmaceutical Pricing Authority on knee implants and cardiac stents have caused other major medtech players to seek to withdraw their devices from […]
Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
🎙️ Tune in to the Ortho Innovation Talks podcast on the DeviceTalks podcast network.
Latest Orthopedics News
Histogenics inks deal to develop Neocart for the Japanese market
Histogenics (NSDQ:HSGX) has inked a deal with Medinet to develop and commercialize its Neocart implant for the Japanese market. The Waltham, Mass.-based company’s Neocart implant is designed to repair knee cartilage damage. The product is made using a patient’s own cells, harvested from the surface of the patient’s femur. Get the full story at our sister site, Drug […]
ConforMIS jumps on analyst’s upgrade
ConforMIS (NSDQ:CFMS) shares closed up more than 12% yesterday after a BTIG analyst upgraded his rating on the company, which makes customized knee and hip implants. BTIG’s Ryan Zimmerman raised his rating on CFMS shares from “neutral” to”buy,” setting a price target of $4 per share. Of the 10 analysts covering the stock, six have set “buy” […]
Johnson & Johnson unit sues ex-rep over defection to Zimmer Biomet
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes leveled a breach of contract lawsuit against a sales rep who quit to work for rival Zimmer Biomet (NYSE:ZBH), alleging that he poached his former customers for his new employer. The lawsuit, filed in the U.S. District Court for Eastern Pennsylvania, alleges that Mario Schackelman jumped ship for Zimmer Biomet […]
Fuse Medical to acquire orthopedics distributor CPM Medical Consultants
Fuse Medical (OTC:FZMD) said yesterday that it agreed to acquire orthopedic implant distributor CPM Medical Consultants for an undisclosed amount. Richardson, Texas-based CPM stocks orthopedic implants and biologics. Fuse Medical said it expects the deal to push its consolidated sales to $35 million next year. The buyout is slated to close by the end of 2017. […]
Zimmer Biomet loses bid to cut $16m plaintiff award in knee suit
A Pennsylvania state appeals court last week upheld a lower court’s award of nearly $16 million in damages against Zimmer Biomet (NYSE:ZBH) in a knee implant lawsuit. The lawsuit filed by Margo Polett claimed that she re-injured her knees while making a Zimmer promotional video, after a double knee replacement procedure in 2006 using the company’s Gender Solutions […]
Study: OrthAlign handheld nav tool reduces fluoroscopy time during THA procedures
OrthAlign’s handheld orthopedic navigation system was reportedly shown to reduce fluoroscopy time in direct-anterior approach total hip arthroplasty procedures. The company’s HipAlign system, which uses imageless technology including sensors that help create a reference plane and provide hip positioning data intraoperatively, was tested by Dr. Edwin Su from New York’s Hospital for Special Surgery. Dr. […]
Wright Medical acquires surgery planning software dev IMASCAP SAS for $89m
Wright Medical (NSDQ:WMGI) said today it inked a deal to acquire shoulder replacement surgery preoperative planning software dev IMASCAP SAS in a deal worth $88.8 million (EU €75.1 million) Through the deal, Wright picked up 100% of IMASCAP’s outstanding equity on a fully diluted basis for a total of $88.8 million, consisting of $46.9 million (EU €39.7 […]
FDA panel votes against recommending Intrinsic Therapeutics’ Barricaid spinal prosthesis
An FDA advisory panel voted 5 to 8 against recommending approval for Intrinsic Therapeutics’s Barricaid prosthesis designed for partial annulus replacement in patients with herniated discs, according to a MedPage Today report. The negative recommendation came based on concerns over the safety of the device, including breakage rate and certain endplate lesions of unknown origin. […]
pSivida touts pilot osteoarthritis trial for Durasert implant
pSivida (NSDQ:PSDV) touted results today from a Phase I safety and efficacy pilot trial of its sustained-release Durasert implant in patients with osteoarthritis of the knee. The company’s Durasert tech, combined with an implantable device from the Hospital for Special Surgery, was designed to continuously deliver a low dose of dexamethasone into the knee joint. Six patients […]
Medtronic to pay $12m to settle Infuse false marketing claims
Medtronic‘s (NYSE:MDT) spinal devices division has agreed to pay $12 million to settle allegations that the medtech giant made false claims to doctors and patients about its Infuse bone-growth protein, according to a Star Tribune report. States joining in the settlement include California, Massachusetts, Illinois, Washington and Oregon, according to the report. In Oregon, Attorney […]